Cefuroxime for Group B Streptococcus UTI
Yes, cefuroxime can be used to treat urinary tract infections caused by Group B Streptococcus (GBS) in adult women, as it is FDA-approved for UTI treatment and all GBS strains demonstrate universal susceptibility to beta-lactam antibiotics including cephalosporins.
Microbiological Rationale
GBS (Streptococcus agalactiae) shows 100% susceptibility to beta-lactam antibiotics including penicillins, ampicillins, and cephalosporins 1. This makes cefuroxime, a second-generation cephalosporin, an appropriate choice from a susceptibility standpoint. The FDA label explicitly lists cefuroxime as indicated for urinary tract infections, though it does not specifically enumerate GBS among the listed organisms 2.
Dosing Recommendations
For uncomplicated UTI caused by GBS:
- 750 mg IV/IM every 8 hours is the FDA-recommended dose 2
- Duration should be at least 10 days when treating infections caused by Streptococcus species to prevent complications such as rheumatic fever or glomerulonephritis 2
- Continue therapy for a minimum of 48-72 hours after the patient becomes asymptomatic or after bacterial eradication is documented 2
Clinical Context and Considerations
GBS accounts for approximately 2% of UTIs in nonpregnant adults 3. When it does occur, it frequently signals underlying urinary tract abnormalities (present in 60% of cases) or chronic renal failure (27% of cases) 3. Screen for structural urinary tract abnormalities when GBS is isolated from urine, as this pathogen's presence is not random 3.
The clinical presentation is evenly split between upper tract (37%) and lower tract (38%) manifestations 3. Despite appropriate treatment, 18% of patients have poor clinical outcomes 3, emphasizing the importance of adequate duration and follow-up.
Treatment Duration Nuance
While current UTI guidelines recommend shorter courses for uncomplicated cystitis (3-5 days for most agents) 4, the FDA label specifically mandates 10 days minimum for Streptococcus pyogenes infections 2. Given that GBS is also a streptococcal species with similar concerns for post-infectious sequelae, applying this 10-day minimum to GBS UTIs is prudent, even though contemporary guidelines don't specifically address GBS duration.
Alternative Considerations
If oral therapy is preferred after initial parenteral treatment:
- Cefuroxime axetil (oral formulation) has demonstrated efficacy in UTI treatment 5, 6, 7
- However, penicillin or ampicillin remain the gold standard for GBS infections given universal susceptibility 1
- Avoid clindamycin (77% resistance) and tetracycline (88% resistance) 1
Critical Pitfall
Do not use aminoglycosides (such as gentamicin) for GBS UTI—all isolates in recent surveillance showed resistance 3. This is particularly important since aminoglycosides are commonly used empirically for gram-negative UTIs.
Pregnancy Consideration
If the patient is pregnant or of childbearing age, GBS bacteriuria requires treatment regardless of symptoms, as it poses significant risk for neonatal infection 1, 8. This is an exception to the general principle of not treating asymptomatic bacteriuria 9.